Dosage Forms I Exam 1 Flashcards

1
Q

2A carboxylic acid with a pKa of 4.8 will be:
a) Partially ionized at pH 5.5
b) nearly completely ionized at pH 1
c) Nearly completely unionized at pH 1
d) a and c
e) a and b

A

d) a and c
partially ionized at pH 5.5 and nearly completely unionized at pH 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The Ka for the dissociation of glibenclamide is 5.0119 x 10^-5. What is its pKa?
a) 9.7
b) 4.3
c) 9.9
d) 4.2
e) 3.85

A

b) 4.3
pKa is the negative log of the ionization constant of an acid
pKa= -logKa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Miconazole is an antifungal drug with a pKa = 6.7
At what pH will the concentration of the unionized and ionized species be equal?
a) pH 4.7
b) pH 8.7
c) pH 7.7
d) pH 5.7
e) pH 6.7

A

e) 6.7
concentrations of the ionized and unionized forms are the same at the pKa (6.7)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Micronazole pKa=6.7
When Micronazole is added to water the pH will:
a) Increase and then decrease
b) decrease
c) stay the same
d) increase
e) decrease and then increase

A

d) increase
pH will increase because miconazole is a weak base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

miconazole pKa= 6.7
What fraction of miconazole is ionized in a buffer at pH 5.9?
a) 0.86
b) 0.14
c) 0.50
d) 0.76
e) 0.24

A

a) 0.86

equation for a weak base: pH-pKa = log B/BH+
5.9-6.7 = -0.8 = LogB/BH+
10^-0.8
B/BH+ = 0.158
Fraction of BH+ = 1/1.158 = 0.86

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Omeprazole is sold as omeprazole magnesium in the tablet formulation. Omeprazole magnesium is:
a) The salt of the weakly acidic drug
b) The acid form of the drug
c) The neutral form
d) The salt of the weakly basic drug
e) the basic form of the drug

A

a) The salt of the weakly acidic drug
Magnesium is a positive ion, so it must be associated with a negative ion. A carboxylic acid or other acidic group would form a negative ion on salt formation, because of transferring a proton. Hence, omeprazole must be an acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the differences between druggability and developability?

A

Druggability- looks at binding as well as “drug-like” properties that are favorable for product translation.
-discovery stage, assess the ability of New Chemical Entities to bind to the drug target, in vivo models are used to assess (research conducted within the body)
Developability- included as a means to characterize if the new molecules can be formulated.
-refers drug product performance, incorporates factors like biorelevant solubility and dissolution, formulation factors related to ADME/T incorporated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the three main areas the control drug performance in patients?

A

Physiochemical properties of the API, Physiochemical properties and the composition of the formulation, Physiological barriers that influence the “targeted bioavailability” of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is drug performance?

A

The ability of a drug to elicit a therapeutic response; can stay in a safe therapeutic range during the dosing regimens; lack of toxic or non-efficacious response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Are excipients inert?

A

excipients are not inert!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Do partition coefficients accurately reflect absorption?

A

No. The GI tract has a diverse pH gradient that uses a buffer instead of water to see solubility which effect pKa. Solubility of water in octanol is about 4% while octanol is 0.4% soluble in water. Octanol looks nothing like the structure of cell membranes–many proteins, glycocalyx, lipids to consider.

The protein to lipid ratio in the GI tract is 1:7:1; thus, octanol:water partitioning is not an accurate predictor of physiological conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the partition coefficient?

A

ratio of concentrations in two immiscible solvents (octanol and water)

Ko/w = C(octanol)/C(water)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pH-Partition hypothesis?

A

For drugs absorbed by a passive, transcellular mechanism across the lipid bilayer; permeability transport depends on the fraction of unionized drug at the intestinal pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Compliance is a big part of patient acceptability. Name the senses that we try to appease for patients with formulations

A

Organoleptic Senses
-sight
-smell
-sound
-taste
-touch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name the individual classes of excipients

A

binders - starches, sugars, cellulose, lactose, sugar alcohols
disintegrants - starches, sugars
fillers (diluents) - starches, sugars, cellulose
Lubricants - magnesium stearate, talc
Glidants (flow enhancers) - silicon dioxide, cellulose, titanium dioxide, talc
Compression aids - starches, sugars, lactose, cellulose
colors - titanium dioxide
sweeteners - sucrose, fructose, dextrose
preservatives - citric acid, sodium citrate, methyl paraben, propyl paraben
dispersing agents - gelatins, starches, gums, cellulose
film formers - polymers
flavors - sodium chloride, citric acid
printing inks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name some ingredients considered in excipient selection
(Those affecting bioavailability, stability, and Marketing Considerations)

A

Disintegrants - enchance rate of disintegrations/dissolution
Coatings- control release
Flavors/sweeteners - mask the taste of the drug
Colors- recognition
Miscellaneous ingredients

17
Q

What are the cardinal rules for drug development and production?

A

1) Know what you have
2) Make the same thing everytime
-this is controlled by specifications

18
Q

What is a monograph and what is its purpose?

A

Come from the USP (United States Pharmacopeia)
reflects quality attributes of a drug
includes: identity, strength, purity and performance

19
Q

What year was the USP established?

A

1820; established by physicians

20
Q

What does the IND do?

A

IND (Investigational Drug Application) is a document that allows for human trials to begin
-must be submitted to FDA

21
Q

What are some challenges for drug design?

A

Short timeline
Broad Dose Range
Small amounts of API
API with different attributes

22
Q

What are the strategies to overcome the challenges of drug design?

A

Determine performance often -assess stability, dissolution, animal pharmacokinetics
Case by case/disease by disease
small scale batches
knowledge-based decision making

23
Q

What is an abbreviated new drug application?

A

data submitted to the FDA for the review and potential approval of a generic drug product

24
Q

What are ADME studies?

A

Absorption, Distribution, Metabolism, Excrement
-studies the rate, the primary and secondary sites, and mechanism of the drug’s metabolism in the body

25
Q

What are some Preformulation studies to worry about?

A

-Drug Solubility
-Partition Coefficient
-Dissolution Rate
-Physical form
-Stability

26
Q

What does Phase I of a clinical investigation involve?

A

Phase I- determines human pharmacology of the drug, structure-activity relationships, side effects with increasing doses, early evidence of effectiveness
-20 to 100 patients
-lasts several months

27
Q

What does phase II of a clinical investigation involve?

A

Phase II- controlled clinical studies for effectiveness in patients with the condition (dose election)
-several hundred patients
-length: several months to 2 years

28
Q

What does Phase III of a clinical investigation involve?

A

Phase III- several hundred to several patients in controlled and uncontrolled trials
Length: 1 to 4 years